A survey of medication responses in children and adolescents with fetal alcohol syndrome

J. Coe, J. Sidders, K. Riley, J. Waltermire, Randi J Hagerman

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


This paper describes the psychopharmacological interventions in patients with Fetal Alcohol Syndrome (FAS), Partial Fetal Alcohol Syndrome (PFAS) or Alcohol-related Neurodevelopmental Disorder (ARND). Methods: The pharmacological histories of patients who had a confirmed in-utero exposure to alcohol and were between the ages of 3.5 and 17 years were collected from a chart review of children seen in a child development unit over the previous seven years. Results: Twenty-two patients had 66 medications trials: 63% responded well to stimulants, 82% responded well to selective serotonin reuptake inhibitors (SSRIs), 88% responded well to a mood stabilizer and 83% responded well to an antipsychotic. Discussion: Aggressive treatment, including medication, should beneficially influence the broad range of secondary disabilities seen in these patients.

Original languageEnglish (US)
Pages (from-to)148-155
Number of pages8
JournalMental Health Aspects of Developmental Disabilities
Issue number4
StatePublished - 2001


  • Antipsychotic
  • Developmental disabilities
  • Fetal alcohol syndrome (FAS)
  • Mental retardation
  • Psychopharmacology
  • SSRI
  • Stimulants

ASJC Scopus subject areas

  • Psychiatry and Mental health


Dive into the research topics of 'A survey of medication responses in children and adolescents with fetal alcohol syndrome'. Together they form a unique fingerprint.

Cite this